Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 61.10
-2.00 (-3.17%)
Jan 21, 2026, 3:05 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 34.29 billion as of January 20, 2026. Its market cap has increased by 164.02% in one year.
Market Cap
34.29B
Enterprise Value
37.25B
Revenue
6.35B
Ranking
n/a
PE Ratio
37.97
Stock Price
61.10
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 34.29B, an increase of 28.64%. That is a compound annual growth rate of 4.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 34.29B | 10.60% |
| Dec 31, 2025 | 31.01B | 140.72% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 62.44B |
| RemeGen | 60.10B |
| Shanghai Junshi Biosciences | 36.33B |
| TransThera Sciences (Nanjing) | 33.06B |
| Duality Biotherapeutics | 31.06B |
| Genscript Biotech | 30.11B |
| Biocytogen Pharmaceuticals (Beijing) | 28.00B |
| InnoCare Pharma | 23.80B |